Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic NephropathyTao Jiang, Moshe Levi, Hideaki Takahashi et al.|Diabetes|2007Cited by 232
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and ObesityXiaoxin X. Wang, Moshe Levi, Komuraiah Myakala et al.|Journal of the American Society of Nephrology|2017Cited by 222
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes ModelXiaoxin X. Wang, Moshe Levi, Tao Jiang et al.|Diabetes|2010Cited by 187
Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 AgonistGiovanni Rizzo, Luciano Adorini, Daniela Passeri et al.|Molecular Pharmacology|2010Cited by 185
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuriaXiaoxin X. Wang, Moshe Levi, Tao Jiang et al.|American Journal of Physiology-Renal Physiology|2009Cited by 182